Fulcrum Therapeutics
FULC
FULC
101 hedge funds and large institutions have $1.01B invested in Fulcrum Therapeutics in 2021 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
51% more funds holding
Funds holding: 67 → 101 (+34)
10.98% more ownership
Funds ownership: 82% → 92.98% (+11%)
26% less call options, than puts
Call options by funds: $2.54M | Put options by funds: $3.44M
Holders
101
Holding in Top 10
5
Calls
$2.54M
Puts
$3.44M
Top Buyers
| 1 | +$69.5M | |
| 2 | +$23.7M | |
| 3 | +$22.4M | |
| 4 |
D.E. Shaw & Co
New York
|
+$15.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$14.2M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$12.1M | |
| 3 | -$9.97M | |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
-$8.01M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.82M |